Analyst Research Report Snapshot

Title:

ACPL: 1QFY14 EPS clocked in at PKR3.69

Price:

$23.00

Provider:

Elixir Securities Pakistan (Pvt.) Limited

Date:

29 Oct 2013

Pages:

3

Type:

AcrobatPDF

Companies referenced:

ATOC.KA

Available for Immediate Download
Summary:

Result announcement Attock Cement Company Limited (ACPL) announced its 1QFY14 financial results on 21st October 2013. The company posted EPS of PKR3.69, up 18% YoY but down 51% QoQ. Exports drove dispatch growth ACPL posted total dispatches of 0.45mn tons during 1QFY14, up 13% YoY. Due to slow local demand, the company relied on exports to maintain a high utilization level. Exports rose to 0.16mn tons during the period, up 63% YoY while local dispatches clocked in at 0.29mn tons, down 3% YoY. Unstable export prices and higher costs contracted gross margins ACPL posted gross margin of PKR95/bag during 1QFY14, down 6% QoQ. Higher power costs during the period caused COGS to clock in at PKR229/bag, up 13% YoY. Owing to unstable export prices, average retention clocked in at PKR324/bag, up by only 7% QoQ. Higher mix of exports increased selling costs Exports comprised of 35% of ACPL’s sales mix during 1QFY14 which translated in to higher selling costs. ACPL posted selling and distribution cost of PKR303mn during the period, up 32% YoY. Investment perspective The stock offers total return of 2% to our Jun-14 target price of PKR125/share. Owing to weak return profile, we maintain our HOLD stance on the stock.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.